Of the many high-molecular-weight antibiotics with antitumor activity, neocarzinostatin (NCS) has been studied most. The amino acid sequence and its conformation have recently been reported by this author et al. (8, 9) . The effectiveness of the drug is most impressive when used in patients with acute leukemia, and complete remission in 50% of the patients treated with NCS alone has recently been reported (4) .
In the present investigation, NCS was subjected to chemical modification with two purposes: (i) to look for a more beneficial derivative, and (ii) to investigate the structural requirements for activity. Chemical investigation has shown previously that there are only two free amino groups. in the molecule, alanine 1 and lysine 20 (7, 9) .
The chemical modification was carried out as follows (1, 6 Biological activities of SUC-II were detectable at 0.4 gg/ml (an arbitrary minimal inhibitory concentration) against Sarcina lutea (5), a gram-positive bacterium, and at 20 to 25% of the NCS dose against human lymphocytic cell clone P3HR-1 derived from a Burkitt lymphoma (3), as judged by cell multiplication. The bacteriological assay was carried out by using a nutrient agar and paper disks, whereas the tests with cells of P3HR-1 were carried out with Eagle minimal essential medium and 10% bovine serum in rubber-stoppered test tubes to which appropriate amounts of the drug were added. After incubation at 37 C, the cells were counted with a hemocytometer. SUC-II at 0.25 gg/ml or higher concentrations showed only cytostatic effect and, unlike NCS, no lytic effect was observed even at 16 qg/ml. SUC-I did not show any activity. In addition to the effect on the floating cell culture of P3HR-1, similar results were obtained with other human cell lines when tested at 0.25 gg/ml or higher concentration.
The results confirm that not only the N-terminal amino group, as described before, but also the e-amino group of lysine do not play an important role in the activity. Furthermore, the increased negative charges of the derivatives should have altered the effects on the pharmacology of the drug such as its stability, permeability, and circulation (transport) properties. Therefore, these results warrant a further evaluation of SUC-II in vivo. Detailed accounts of chemical and biological characteristics of SUC-I and SUC-IT will be published elsewhere.
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